BRIM Biotechnology, Inc. (6885.TWO)
TWD 37.6
(0.0%)
TWD 37.6
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.59 Million TWD | -44.22% |
| 2022 | 6.44 Million TWD | 103.6% |
| 2021 | 3.16 Million TWD | -49.16% |
| 2020 | 6.22 Million TWD | 4104.05% |
| 2019 | 148 Thousand TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.5 Million TWD | -30.32% |
| 2024 Q2 | 1.52 Million TWD | -38.99% |
| 2023 Q4 | 3.59 Million TWD | 3225.93% |
| 2023 Q2 | 5.74 Million TWD | 0.0% |
| 2023 Q1 | - TWD | -100.0% |
| 2023 FY | 3.59 Million TWD | -44.22% |
| 2023 Q3 | 108 Thousand TWD | -98.12% |
| 2022 Q3 | 2.81 Million TWD | 0.0% |
| 2022 Q4 | 6.44 Million TWD | 128.86% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sagittarius Life Science Corp | 13.32 Million TWD | 73.039% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | 66.735% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 99.108% |
| VBI | - TWD | -Infinity% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 98.878% |
| Visgeneer Inc. | 158.6 Million TWD | 97.735% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | 33.861% |
| EirGenix Inc. | 465.16 Million TWD | 99.228% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 93.829% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 99.082% |
| RBC Bioscience Corporation | 487.36 Million TWD | 99.263% |
| BiOptic Inc. | 93.19 Million TWD | 96.146% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -159.725% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -567.658% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 75.012% |
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 96.834% |
| Level Biotechnology Inc. | 13.5 Million TWD | 73.397% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 96.293% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 99.522% |
| GlycoNex Incorporation | 900 Thousand TWD | -299.111% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 98.603% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -69.915% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 98.733% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 99.505% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 97.937% |
| Neith Corporation | 3.54 Million TWD | -1.44% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.818% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -206.746% |
| Enimmune corporation | 45.73 Million TWD | 92.146% |
| TaiRx, Inc. | 12.28 Million TWD | 70.763% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Lin BioScience, Inc. | 42.87 Million TWD | 91.622% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -312.874% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 72.563% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 95.649% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 99.473% |
| NaviFUS Corp. | 32.69 Million TWD | 89.013% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 99.139% |
| Sinew Pharma Inc. | 6.46 Million TWD | 44.431% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 86.756% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 98.169% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 71.515% |
| AP Biosciences Inc | 82.07 Million TWD | 95.624% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.877% |
| 3D Global Biotech Inc. | 10.37 Million TWD | 65.392% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 97.512% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 99.75% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 99.097% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | 17.501% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | 54.937% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | 39.098% |
| TCI GENE Inc. | 6.79 Million TWD | 47.138% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | 56.817% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | 62.587% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 98.663% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | 66.373% |
| PharmaEngine, Inc. | 14.8 Million TWD | 75.744% |
| Savior Lifetec Corporation | 270.37 Million TWD | 98.671% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 95.191% |
| OBI Pharma, Inc. | 501.05 Million TWD | 99.283% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 89.447% |
| Acepodia, Inc. | 273.81 Million TWD | 98.688% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 82.442% |